Company: SVREW
Filing Date: 2025-07-01
Form Type: F-1
Source: 0001213900-25-060400
Chunk: 35

Company: SaverOne 2014 Ltd.
Filing Date: 2025-07-01
Form: F-1
Chunk 35
---
 on numerous factors, including our ability to obtain additional
financing and changes we may make to our development plan. As a result, our management will have broad discretion in the application of
the net proceeds, which may include uses not set forth above, and investors will be relying on our judgment regarding the application
of the net proceeds from this offering.

Pending our use of proceeds
from the SEPA, we plan to invest the net proceeds from this offering in a variety of investment-grade instruments and/or to hold such
proceeds as cash or interest-bearing deposits, in the currencies in which we expect to make payment.

<div align='center'>CAPITALIZATION</div>

The following table sets forth our total capitalization
as of December 31, 2024:

| ● | on an actual basis; |

| ● | on pro forma basis, after giving effect to the issuance and sale of 3,130,608,000 Ordinary Shares represented by 869,614 ADSs (after giving retroactive effect to the new ratio of 3,600 ordinary shares for each ADS) for gross proceeds of approximately $5.5 million, which have been issued to Yorkville pursuant to the standby equity purchase agreement dated July 16, 2024, as amended, as if the sale of the securities had occurred on December 31, 2024, as well as the issuance and sale of 195,428,970 Ordinary Shares represented by 54,300 ADSs (after giving retroactive effect to the new ratio of 3,600 Ordinary Shares for each ADS) to several institutional investors in a registered direct offering for gross proceeds of approximately $1.5 million. |
| ● | on a pro forma as adjusted basis, to give further effect to the issuance and sale of 5,760,000,000 Ordinary Shares representing 1,600,000 ADSs pursuant to this Registration Statement at an assumed offering price of $2.97 per ADS, which is the last reported sales price of our ADSs on Nasdaq on June 30, 2025, after deducting the estimated offering expenses by us.                                                                                                                                                                                                                                                                                                                                                                                                  |

<div align='center'>17</div>

You should read this information
in conjunction with our financial statements and the related notes incorporated by reference in this prospectus.

|                                                                                                                                                                                                                                       |     | As of December 31, 2024 |          |   |     |               |         |   |     |            |          |   |     |